Evidence map›Paper›PMID 35134071›Full record

ArticlePloS one2022

Principal investigators over-optimistically forecast scientific and operational outcomes for clinical trials.

Daniel M Benjamin, Spencer P Hey, Amanda MacPherson, Yasmina Hachem, Kara S Smith, Sean X Zhang, Sandy Wong, Samantha Dolter, David R Mandel, Jonathan Kimmelman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Daniel M BenjaminHuizenga College of Business and Entrepreneurship, Nova Southeastern University, Ft Lauderdale, FL, United States of America.
Spencer P HeyCenter for Bioethics, Harvard Medical School, Boston, MA, United States of America.
Amanda MacPhersonStudies in Translation, Ethics and Medicine, Biomedical Ethics Unit, McGill University, Montreal, QC, Canada.
Yasmina HachemStudies in Translation, Ethics and Medicine, Biomedical Ethics Unit, McGill University, Montreal, QC, Canada.
Kara S SmithStudies in Translation, Ethics and Medicine, Biomedical Ethics Unit, McGill University, Montreal, QC, Canada.
Sean X ZhangStudies in Translation, Ethics and Medicine, Biomedical Ethics Unit, McGill University, Montreal, QC, Canada.
Sandy WongStudies in Translation, Ethics and Medicine, Biomedical Ethics Unit, McGill University, Montreal, QC, Canada.
Samantha DolterStudies in Translation, Ethics and Medicine, Biomedical Ethics Unit, McGill University, Montreal, QC, Canada.
David R MandelYork University, Toronto, ON, Canada.ORCID 0000-0003-1036-2286
Jonathan KimmelmanStudies in Translation, Ethics and Medicine, Biomedical Ethics Unit, McGill University, Montreal, QC, Canada.ORCID 0000-0003-1614-6779
McGill University · CAHarvard University · USNova Southeastern University · USYork University · CA

Funding

CIHR EOG 201303
6 · The paper itself

Abstract

objectiveTo assess the accuracy of principal investigators' (PIs) predictions about three events for their own clinical trials: positivity on trial primary outcomes, successful recruitment and timely trial completion. STUDY DESIGN AND

settingA short, electronic survey was used to elicit subjective probabilities within seven months of trial registration. When trial results became available, prediction skill was calculated using Brier scores (BS) and compared against uninformative prediction (i.e. predicting 50% all of the time).

results740 PIs returned surveys (16.7% response rate). Predictions on all three events tended to exceed observed event frequency. Averaged PI skill did not surpass uninformative predictions (e.g., BS = 0.25) for primary outcomes (BS = 0.25, 95% CI 0.20, 0.30) and were significantly worse for recruitment and timeline predictions (BS 0.38, 95% CI 0.33, 0.42; BS = 0.52, 95% CI 0.50, 0.55, respectively). PIs showed poor calibration for primary outcome, recruitment, and timelines (calibration index = 0.064, 0.150 and 0.406, respectively), modest discrimination in primary outcome predictions (AUC = 0.76, 95% CI 0.65, 0.85) but minimal discrimination in the other two outcomes (AUC = 0.64, 95% CI 0.57, 0.70; and 0.55, 95% CI 0.47, 0.62, respectively).

conclusionPIs showed overconfidence in favorable outcomes and exhibited limited skill in predicting scientific or operational outcomes for their own trials. They nevertheless showed modest ability to discriminate between positive and non-positive trial outcomes. Low survey response rates may limit generalizability.

Indexed as

ForecastingClinical Trials as TopicHumansResearch PersonnelSurveys and QuestionnairesTreatment Outcome

Identifiers

PMID35134071
PMCPMC8824379
OpenAlexW4210898176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.